Eisai Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Eisai Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013641
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eisai Inc (Eisai) is a healthcare company, which focuses on the discovery, development and marketing of pharmaceutical products. The company’s major products include Aricept for Alzheimer’s treatment, Aciphex for acid reflux, Akynzeo for nausea and vomiting dring the course of cancer chemotherapy, Aloxi anti-nausea medication injection, Banzel for adjunctive treatment and Panretin for the treatment of skin lesions in AIDS-related Kaposi’s sarcoma. The company’s research and development activities focus on therapeutic areas such as neuroscience; cancer, antibody-based programs; vascular, inflammatory and immunological reaction. Eisai established partnerships and collaborations with global companies such as Pfizer Inc., Janssen Pharmaceutica Inc., and Elan Pharma International Limited and Elan Pharmaceutical Inc for the development and distribution of drugs. The company is a subsidiary of Eisai Co., Ltd. and is headquartered in New Jersey, the US.

Eisai Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Eisai Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Eisai Inc, Medical Devices Deals, 2011 to YTD 2017 9
Eisai Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Eisai Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Oncology Venture and Eisai Enter into Agreement 12
Eisai Enters into Research Agreement with Oklahoma Medical Research Foundation 13
Novartis Pharma Enters into Agreement with Eisai 14
Eisai Enters into Research Agreement with Paoli Calmettes Institute 15
Eisai Enters into Agreement with Purdue Pharma 16
Eisai Enters into Co-Marketing Agreement with Esteve for Zonegran 17
Eisai Amends its Co-Marketing Agreement with Arena Pharma for Belviq 18
Arena Pharma Expands Co-Marketing Agreement With Eisai For Lorcaserin 20
Licensing Agreements 21
Grupo Biotoscana Enters into Licensing Agreement with Eisai 21
Oncology Venture Enters into Licensing Agreement with Eisai 22
Otsuka Pharma Enters Into Licensing Agreement With Eisai 23
Eisai Enters Into Licensing Agreement With Generic Drug Manufacturer For Donepezil HCl 23mg 24
Asset Transactions 25
Concordia Pharmaceuticals Acquires Zonegran from Eisai for USD91.5 Million 25
Sarepta Therapeutics to Acquire Manufacturing Plant in Massachusetts from Eisai for USD25 Million 27
Valeant Pharma Acquires US Rights To Targretin From Eisai For US$65 Million 28
Arbor Pharma To Acquire US Rights For Gliadel Wafer From Eisai 29
Acquisition 31
Dova Pharma Acquires AkaRx from Eisai 31
Robert Bosch Completes Acquisiton Of Eisai Machinery 32
Eisai Inc – Key Competitors 34
Eisai Inc – Key Employees 35
Eisai Inc – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Recent Developments 37
Strategy And Business Planning 37
Sep 15, 2016: Eisai Establishes AiM Institute to Discover Human Biology Driven Precision Medicines 37
Other Significant Developments 39
Oct 23, 2017: Oncology Venture Updates on Pipeline and Business 39
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Eisai Inc, Pharmaceuticals & Healthcare, Key Facts 2
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Eisai Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Eisai Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Eisai Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Eisai Inc, Medical Devices Deals, 2011 to YTD 2017 9
Eisai Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oncology Venture and Eisai Enter into Agreement 12
Eisai Enters into Research Agreement with Oklahoma Medical Research Foundation 13
Novartis Pharma Enters into Agreement with Eisai 14
Eisai Enters into Research Agreement with Paoli Calmettes Institute 15
Eisai Enters into Agreement with Purdue Pharma 16
Eisai Enters into Co-Marketing Agreement with Esteve for Zonegran 17
Eisai Amends its Co-Marketing Agreement with Arena Pharma for Belviq 18
Arena Pharma Expands Co-Marketing Agreement With Eisai For Lorcaserin 20
Grupo Biotoscana Enters into Licensing Agreement with Eisai 21
Oncology Venture Enters into Licensing Agreement with Eisai 22
Otsuka Pharma Enters Into Licensing Agreement With Eisai 23
Eisai Enters Into Licensing Agreement With Generic Drug Manufacturer For Donepezil HCl 23mg 24
Concordia Pharmaceuticals Acquires Zonegran from Eisai for USD91.5 Million 25
Sarepta Therapeutics to Acquire Manufacturing Plant in Massachusetts from Eisai for USD25 Million 27
Valeant Pharma Acquires US Rights To Targretin From Eisai For US$65 Million 28
Arbor Pharma To Acquire US Rights For Gliadel Wafer From Eisai 29
Dova Pharma Acquires AkaRx from Eisai 31
Robert Bosch Completes Acquisiton Of Eisai Machinery 32
Eisai Inc, Key Competitors 34
Eisai Inc, Key Employees 35
Eisai Inc, Other Locations 36
Eisai Inc, Subsidiaries 36

★海外企業調査レポート[Eisai Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Integrity Applications Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Integrity Applications Ltd (Integrity Applications) is a medical device company that designs, develops and markets non-invasive glucose monitoring devices. The company develops GlucoTrack, a glucose monitoring device which utilizes ultrasonic, electromagnetic and thermal technologies to meas …
  • Atossa Genetics Inc:企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Marshall of Cambridge (Holdings) Ltd:戦略・SWOT・企業財務分析
    Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Marshall of Cambridge (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Boston Children’s Hospital:企業の戦略的SWOT分析
    Boston Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ecobliss Holding BV:企業の戦略・SWOT・財務情報
    Ecobliss Holding BV - Strategy, SWOT and Corporate Finance Report Summary Ecobliss Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • John B. Sanfilippo & Son Inc:企業の戦略・SWOT・財務分析
    John B. Sanfilippo & Son Inc - Strategy, SWOT and Corporate Finance Report Summary John B. Sanfilippo & Son Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • GFI Informatique:企業の戦略・SWOT・財務分析
    GFI Informatique - Strategy, SWOT and Corporate Finance Report Summary GFI Informatique - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • KPJ Healthcare Berhad (KPJ):企業の財務・戦略的SWOT分析
    Summary KPJ Healthcare Berhad (KPJ) is a healthcare service provider that offers medical services. The center offers services in the areas of anaesthesiology, cardiology and cardiothoracic surgery, child psychiatry, clinic pathology, occupational health services, orthopaedic and trauma surgery, diet …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TRACON Pharmaceuticals Inc (TCON):企業の財務・戦略的SWOT分析
    Summary TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company that develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TRC253, TRC694, and TRC205. Its lead product …
  • The Medicines Company (MDCO):製薬・医療:M&Aディール及び事業提携情報
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products a peptide compound that inhibits an intravenous direct thrombin and needle …
  • Symetra Life Insurance Company:企業の戦略・SWOT・財務情報
    Symetra Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Symetra Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Oneok Inc (OKE):企業の財務・戦略的SWOT分析
    Oneok Inc (OKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Black River Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Black River Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Accelerate Diagnostics Inc (AXDX):医療機器:M&Aディール及び事業提携情報
    Summary Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in …
  • CellProthera-製薬・医療分野:企業M&A・提携分析
    Summary CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissu …
  • International Flavors & Fragrances Inc (IFF):企業の財務・戦略的SWOT分析
    International Flavors & Fragrances Inc (IFF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Sisaf Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Smrt Corporation Ltd.
    Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report Summary Smrt Corporation Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆